Home » Topics » Regulatory » Patents

Patents
RSS

New Astra compounds for the therapy of 5-HT-mediated disorders

March 5, 1999

Antiulcer PGE analogues developed at Taisho

March 5, 1999

Taisho scientists isolate and and characterize new antifungal agent

March 5, 1999

Rhone-Poulenc Rorer describes new hypoglycemic series

March 5, 1999

Pfizer claims new, improved compositions of alatrofloxacin

March 4, 1999

Platelet aggregation inhibitors in development at SmithKline Beecham

March 4, 1999

Dual 5-HT reuptake inhibitors/5-HT1A antagonists patented by Lundbeck

March 4, 1999

New heterocyclic compounds from Searle preferentially inhibit iNOS

March 4, 1999

New lantibiotic isolated and characterized by U. of Maryland group

March 4, 1999

Cytokine production inhibitors prepared and tested at Ortho-McNeil

March 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...